Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
HIV-1-infection
Interventions
DRUG

B/F/TAF

Tablet for oral suspension administered

Trial Locations (4)

2001

RECRUITING

WITS RHI Shandukani Research Centre, Johannesburg

7505

RECRUITING

Family Centre for Research with Ubuntu (FAMCRU), Cape Town

30322

NOT_YET_RECRUITING

Grady Health System - Ponce de Leon Center, Atlanta

38105

RECRUITING

St Jude Children's Research Hospital, Memphis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY